Semler Scientific, Inc. develops, manufactures, and markets products and services that assist in evaluating and treating chronic diseases. The Company provides technology solutions to healthcare providers. The Company's flagship product, QuantaFlo is a four-minute in-office blood flow test. Healthcare providers can use blood flow measurements as part of their examinations of a patient’s vascular condition, including assessments of patients who have vascular disease. QuantaFlo features a sensor clamp that is placed on the toe or finger. Infrared light emitted from the clamp on the dorsal surface of the digit is scattered and reflected by the red blood cells coursing through the area of illumination. Returning light is sensed by the sensor. A blood flow waveform is instantaneously constructed by its proprietary software algorithm. Its customers for QuantaFlo include insurance plans, physician groups, risk assessment groups, hospitals and retailers.
成長中
同社は成長フェーズにあり、最新の年間収益はUSD 56.29Mに達しています。
高い利益成長
同社の純利益は業界をリードしており、最新の年間純利益はUSD 185.51です。
割安
同社の最新のPEは5.91で、過去3年間の水準と比較して安値圏にあります。
機関投資家の売り越し
最新の機関投資家の保有株数は9.46M株で、前四半期比で23.54%減少しています。
バンガードが保有
スター投資家バンガードは本銘柄を639.47K株保有しています。
市場活動が低調
同社への投資家の関心は低下しており、20日間の売買回転率は0.24です。